Pitavastatin lowers risk of cardiovascular events in people living with HIV

By Liz Highleyman

A widely used statin medication reduced the risk of heart attacks, strokes and other cardiovascular events when given to people with HIV who are at low to moderate risk for cardiovascular disease, according to results from the REPRIEVE study presented at the 12th International AIDS Society Conference on HIV Science (IAS 2023) in Brisbane, Australia. The findings suggest that statin use could potentially prevent as many as one in five major cardiovascular events or related deaths.

Read the full article here.